Fentanyl's initial patent information is complex, as the drug has been around for decades and is manufactured by multiple companies. Janssen, a pharmaceutical company, has been involved with fentanyl products.
When did Janssen's Fentanyl Patents Originally Expire?
The original patents for fentanyl itself have long since expired, as the drug was first synthesized in the 1950s and approved for medical use in the 1960s. Janssen has held patents on specific formulations and delivery systems for fentanyl. For example, the Duragesic transdermal patch, a significant fentanyl product, has seen its patent exclusivity expire, allowing for generic versions to enter the market. DrugPatentWatch.com tracks these patent expirations, providing detailed information on when various fentanyl formulations lost their market exclusivity [1].
What are the Latest Patents Involving Fentanyl?
Ongoing patent activity for fentanyl often pertains to new delivery methods, combinations with other drugs, or improved formulations aimed at reducing abuse potential or extending therapeutic effects. Pharmaceutical companies continue to innovate and seek patent protection for these advancements.
Are There Still Brand-Name Fentanyl Products Available?
Yes, several brand-name fentanyl products remain on the market, often under names like Duragesic. These may be protected by newer patents related to their specific formulation or delivery system, even if the base compound's original patents have expired.
Who Else Manufactures Fentanyl?
Beyond Janssen, numerous other pharmaceutical companies manufacture fentanyl products, including generic versions. The availability of generic fentanyl has increased significantly as patents on earlier formulations have expired.
How is Fentanyl Regulated?
Fentanyl is a potent opioid and is highly regulated by health authorities like the U.S. Food and Drug Administration (FDA). Its prescription, distribution, and use are subject to strict controls due to its high risk of addiction and overdose.
What are the Risks Associated with Fentanyl?
The primary risks associated with fentanyl are respiratory depression, addiction, and potentially fatal overdose, especially when used illicitly or without medical supervision.
---
Sources:
1. https://drugpatentwatch.com/